Kopran Ltd.
KOPRAN Share PricePharmaceuticals & Drugs
₹139.79
-0.8 (-0.5%)
As on December 4, 2025
Exchange Scrips: BSE524280NSEKOPRANISININE082A01010
Market Cap ₹ 672 Cr
P/E Ratio 17.51
Dividend Yield 0.21 %
Performance
Market performance
Open141.43
High142.5
Volumes89,616
Prev139.79
Low137.41
As on2025-12-04
Historical performance
1 Year High227.1
3 Year High369.7
5 Year High370.45
1 Year Low123.11
3 Year Low96
5 Year Low96
Fundamentals
Company Valuation
Market Cap (₹Cr)
672
Face Value (₹)
10
P/E Ratio
17.51
Dividend Yield
0.21 %
Investment Returns
1 Year
-34.9%
3 Years
-15.3%
5 Years
3.1%
10 Years
75.2%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 140.04 | Bearish |
| 10-DMA | 135.35 | Bullish |
| 20-DMA | 140.55 | Bearish |
| 50-DMA | 158.77 | Bearish |
| 100-DMA | 163.78 | Bearish |
| 200-DMA | 173.93 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 9 | 17 | 18 | 19 | 20 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 9 | 17 | 18 | 19 | 20 |
| Public Investors | 62212 | 60176 | 58633 | 60540 | 57133 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 17.51.
- 3Y Stock Price CAGR of the stock is -5.3.
- The stock has a beta of 1.2.
- In the last financial year, the company had an EBITDA of ₹769 Million.
- The company generated revenue of ₹6296 Million in the previous financial year.
Kopran Ltd.
139.79-0.8 (-0.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 655460.2
No. of Shares: 4689 (Approx)
Performance:-34.5%
P/L: ₹-344539.8
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
